Bio Essence Corp Balance Sheet
BIOE|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$422,474
FY2025
Cash
N/A
Cash and equivalents
Total Debt
$57,482
FY2025
Shareholder Equity
-$2M
FY2025
Bio Essence Corp had $422,474 in total assets with negative shareholders' equity of $2M as of FY2025. Total debt stood at $57,482 as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 8/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
- Cash-backed earnings: Operating cash flow exceeds net income
- Profit margin: 47.2% of revenue retained as profit
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | - | $1.4K | $114 | $6.3K | $303 |
| Accounts Receivable | $23.5K | $5.1K | $35.1K | $5.6K | $16.8K |
| Inventory | - | - | $143.3K | $181.2K | $213.0K |
| Current Assets | $422.4K | $280.7K | $300.0K | $203.8K | $262.0K |
| PP&E (Net) | - | - | $3.7K | $246.4K | $180.9K |
| Total Assets | $422.5K | $281.0K | $2.8M | $1.5M | $1.7M |
| Current Liabilities | $2.4M | $2.8M | $2.5M | $3.6M | $2.8M |
| Total Debt | $57.5K | $56.5K | - | - | - |
| Shareholders' Equity | -$2.1M | -$3.0M | -$1.7M | -$3.2M | -$2.4M |